RT Journal Article
SR Electronic
T1 SARS-CoV-2 infection risk among unvaccinated is negatively associated with community-level vaccination rates
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.03.26.21254394
DO 10.1101/2021.03.26.21254394
A1 Oren Milman
A1 Idan Yelin
A1 Noga Aharony
A1 Rachel Katz
A1 Esma Herzel
A1 Amir Ben-Tov
A1 Jacob Kuint
A1 Sivan Gazit
A1 Gabriel Chodick
A1 Tal Patalon
A1 Roy Kishony
YR 2021
UL http://medrxiv.org/content/early/2021/03/29/2021.03.26.21254394.abstract
AB Mass vaccination has the potential to curb the current COVID-19 pandemic by protecting vaccinees from the disease and possibly lowering the chance of transmission to unvaccinated individuals. The high effectiveness of the widely-administered BNT162b vaccine in preventing not only the disease but also infection suggests a potential for a population-level effect, critical for disease eradication. However, this putative effect is difficult to observe, especially in light of highly fluctuating spatio-temporal epidemic dynamics. Here, analyzing vaccination records and test results collected during a rapid vaccine rollout for a large population from 223 geographically defined communities, we find that the rates of vaccination in each community are highly correlated with a later decline in infections among a cohort of under 16 years old which are unvaccinated. These results provide observational evidence that vaccination not only protects individual vaccinees but also provides cross-protection to unvaccinated individuals in the community.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the ISRAEL SCIENCE FOUNDATION (grant No. 3633/19) within the KillCorona-Curbing Coronavirus Research Program.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study protocol was approved by the ethics committee of Maccabi Healthcare Services, Tel-Aviv, Israel. The IRB includes an exempt from informed consent.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesDue to patient privacy concerns, data is only available through a remote server, pending MTA.